Adsorption of chain type-specific ABO antibodies on Sepharose-linked A and B tetrasaccharides

Transfusion

Volumn 52, Issue 11, 2012, Pages 2356-2367

  Lindberg, Linda ^a   Theinert, Katharina ^a   Liu, Jining ^a   Holgersson, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

A TETRASACCHARIDE; B TETRASACCHARIDE; GLYCOPROTEIN; IMMUNOGLOBULIN G; SEPHAROSE; TETRASACCHARIDE; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NORMAL HUMAN;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES; ANTIBODY SPECIFICITY; BLOOD GROUPING AND CROSSMATCHING; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTOCOMPATIBILITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; KIDNEY TRANSPLANTATION; OLIGOSACCHARIDES; SEPHAROSE; TRANSPLANTATION IMMUNOLOGY;

EID: 84869225951     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03706.x     Document Type: Article

References (30)

1. Cecka JM,. The OPTN/UNOS renal transplant registry. Clin Transpl 2005; 1-16.
2. Squifflet J-P, De Meyer M, Malaise J, Latinne D, Pirson Y, Alexandre GP,. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant 2004; 2: 208-13.
3. Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G,. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85: 1745-54.
4. Tyden G, Kumlien G, Fehrman I,. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730-1.
5. Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I,. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145-8.
6. Clausen H, Hakomori S,. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 1989; 56: 1-20.
7. Holgersson J, Breimer ME, Samuelsson BE,. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. APMIS Suppl 1992; 27: 18-27.
8. Rydberg L, Breimer ME, Holgersson J, Karlsson KA, Nyholm PG, Pascher I, Svensson L, Samuelsson BE,. Characterisation of the anti-A antibody response following an ABO incompatible (A2 to O) kidney transplantation. Mol Immunol 1992; 29: 547-60.
9. Rydberg L, Nyberg G, Attman PO, Mjörnstedt L, Tufveson G, Blohme I,. Characterization of the anti-A antibody binding in an ABO-incompatible living donor renal transplantation. Nephrol Dial Transplant 1994; 9: 1162-5.
10. Lindberg L, Johansson SM, Liu J, Grufman P, Holgersson J,. Is there a clinical need for a diagnostic test allowing detection of chain type-specific anti-A and anti-B? Transfusion 2011; 51: 494-503.
11. Kumlien G, Ullstrom L, Losvall A, Persson LG, Tydén G,. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568-75.
12. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer ME,. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to Sepharose. Transpl Int 2005; 17: 666-72.
13. Lanning DK, Rhee K-J, Knight KL,. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol 2005; 26: 419-25.
14. Springer GF, Horton RE,. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J Clin Invest 1969; 48: 1280-91.
15. Höstrup H,. Influence of foetal A and B blood-group substances on the immunization of pregnant women. Vox Sang 1964; 9: 301-14.
16. Koskela P, Nurmi T, Häivä V-M,. IgA, IgG and IgM anti-blood group A antibodies induced by pneumococcal vaccine. Vaccine 1988; 6: 221-2.
17. Preece AF, Strahan KM, Devitt J, Yamamoto F, Gustafsson K,. Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement. Blood 2002; 99: 2477-82.
18. Rieben R, Buchs JP, Fluckiger E, Nydegger UE,. Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories. Transfusion 1991; 31: 607-15.
19. Furukawa K, Welt S, Yin BWT, Feickert HJ, Takahashi T, Ueda R, Lloyd KO,. Analysis of the fine specificities of 11 mouse monoclonal antibodies reactive with type 2 blood group determinants. Mol Immunol 1990; 27: 723-32.
20. Mollicone R, Cailleau A, Imberty A, Gane P, Perez S, Oriol R,. Recognition of the blood group H type 2 trisaccharide epitope by 28 monoclonal antibodies and three lectins. Glycoconj J 1996; 13: 263-71.
21. Imberty A, Mollicone R, Mikros E, Carrupt PA, Pérez S, Oriol R,. How do antibodies and lectins recognize histo-blood group antigens? A 3D-QSAR study by comparative molecular field analysis (CoMFA). Bioorg Med Chem 1996; 4: 1979-88.
22. Nyholm PG, Samuelsson BE, Breimer ME, Pascher I,. Conformational analysis of blood group A-active glycosphingolipids using HSEA-calculations. The possible significance of the core oligosaccharide chain for the presentation and recognition of the A-determinant. J Mol Recognit 1989; 2: 103-13.
23. Imberty A, Mikros E, Koca J, Mollicone R, Oriol R, Pérez S,. Computer simulation of histo-blood group oligosaccharides: energy maps of all constituting disaccharides and potential energy surfaces of 14 ABH and Lewis carbohydrate antigens. Glycoconj J 1995; 12: 331-49.
24. Gustafsson A, Holgersson J,. A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions. Expert Opin Drug Discov 2006; 1: 161-78.
25. Lofling J, Holgersson J,. Core saccharide dependence of sialyl Lewis X biosynthesis. Glycoconj J 2009; 26: 33-40.
26. Bensinger WI, Baker DA, Buckner CD, Clift RA, Thomas ED,. Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med 1981; 304: 160-2.
27. Agishi T, Takahashi K, Ota K, Yagisawa T,. Comparative evalutation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or anti-B antibody in ABO-incompatible kidney transplantation. Transplant Proc 1992; 24: 557-8.
28. Berkman EM, Caplan S, Kim CS,. ABO-incompatible bone marrow transplantation: preparation by plasma exchange and in vivo antibody absorption. Transfusion 1978; 18: 505-8.
29. Rieben R, Korchagina EY, von Allmen E, Hovinga JK, Lammle B, Jungi TW, Bovin NV, Nydegger UE,. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 1995; 60: 425-30.
30. Valli PV, Puga Yung G, Fehr T, Schulz-Huotari C, Kaup N, Güngör T, Ambühl P, Weber M, Schanz U, Seebach JD, Stussi G,. Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. Am J Transplant 2009; 9: 1072-80.